; Whereas regular annual United States appropriations for global health have increased by merely 10.6 percent to $11,300,000,000 since 2010, and have been outpaced by both inflation and the United States economic growth; Whereas relative to the size of the United States economy, the United States official overseas development spending is low at 0.17 percent of gross national income (GNI) in 2020, placing the United States 24th out of the 29 country members of the Organization for Economic Co-operation and Development’s Development Assistance Committee, and meeting just one-fourth of the United Nations official development assistance target of 0.7 percent GNI; Whereas dramatically increasing foreign aid may have voter support, given that opinion polls consistently find that Americans believe United States foreign aid should make up approximately 10 percent of the Federal budget; Whereas historically, United States and other global North-supported global health programs have inadvertently entrenched standards of care in low-income countries that would be unacceptable in rich countries by funding only health services narrowly defined as sustainable , cost-effective , or appropriate in poor settings; Whereas the effectiveness and efficiency of current United States overseas development assistance for health is often undermined by— (1) misalignment with countries’ national health plans; (2) bypassing delivery systems with parallel inputs, leading to fragmentation of care delivery, poor donor coordination across partners, and weak health systems; (3) favoring technical assistance from consultants from high-income countries, especially the United States, over funding health service delivery in beneficiary countries; and (4) promoting privatization of health services, thereby undermining public system strengthening, health care access, health equity, and financial risk protection